2008 Top 20 Pharmaceutical Companies Report

The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007. Several companies still managed to post solid gains during the year, but even they were haunted by the specter of patent expirations to come. It was a tough year at many of these companies, with layoffs reaching the tens of thousands. New leadership teams, with chief executives not much older than your humble editor, have inherited truly untenable situations. —Gil Y. Roth, EditorContributors Editor: Gil Y. Roth Associate Editor: Kristin Brooks Contributing Editor: Derek B. Lowe All profiles written by Gil Roth, except Abbott Laboratories, by Kristin Brooks. The Lowe Down capsules written by Derek Lowe All pipeline information compiled by Kristin Brooks Sales information compiled by Gil Roth Looking for the Top 10 Biopharma companies report? Look no further!